Harvard Women's Health Watch

In the news: FDA approves one drug for irritable bowel syndrome but suspends another

The FDA has approved a new medication for constipation-predominant irritable bowel syndrome, soon after suspending another drug and restricting it to use only in emergency situations.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In